In this study, ERCC6L was found to be highly expressed in BC patients, and its expression level was positively correlated with the malignant grade of the tumor and the poor prognosis of patients, which to some extent suggested that ERCC6L played an essential role in the malignant progression of BC. This evidence concerns the gene ERCC6L and neoplasm.